Sorry, I couldn't work out how to edit my post about CSL which was not quite correct. They actually spent $1B developing the drug and market cap dropped $8 Billion.
Just because RCE has $90 M market cap does not mean that drug development costs are proportionately smaller. The $1 B cost is typical of first to market cost of a new class of medications.
And "probably soon be recovered". Well I waited 3 years with no stock market movement on CSL and sold recently.
Ann: Safety Committee Approves Expansion of Ph I/II DFI Trial, page-26
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
-0.015(2.73%) |
Mkt cap ! $124.0M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 55.0¢ | 53.5¢ | $140.7K | 258.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3013 | 53.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 6356 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |